The pandemic has spurred rapid innovation in the field of diagnostics, and today there are new platforms that bring molecular testing directly to the point of care – offering an alternative to lab-based PCR testing that is more rapid, flexible and clinically efficient. The most rapid of these new tests, Abbott’s ID NOW™ COVID-19, utilizes Nicking Enzyme Amplification Reaction (NEAR) isothermal technology to deliver accurate SARS-CoV-2 results in 13 minutes or less, enabling healthcare providers to make evidence-based clinical decisions sooner. 

With the sensitivity of PCR now available at the point of care, healthcare workers no longer have to sacrifice accuracy for speed.

Download the infographic now! 

Sponsored By